Sign in

CIK 0002114044 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Hemab Therapeutics Holdings, Inc.

Sign in to watch
Ticker
COAG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
414241952
Phone
45 2138 7627
Business address
101 MAIN STREET, SUITE 1220, CAMBRIDGE, MA, 02142
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. 4 Insider Changes in Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Executive or director change
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G Stake Statement of Beneficial Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 4 Insider Changes in Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 3 · 53 filings